Essentials of ocular pharmacology and therapeutics

Sengupta, K. K.; Mukherji, R.; Sainani, Ashwin
June 2006
Indian Journal of Ophthalmology;Jun2006, Vol. 54 Issue 2, p141
Book Review
Reviews the book "Essentials of Ocular Pharmacology and Therapeutics," first edition, by K. K. Senguptaand R. Mukherji.


Related Articles

  • Aligning with evolution provides tremendous opportunity. Radhakrishnan // Paintindia;Dec2012, Vol. 62 Issue 12, p122 

    The article discusses the highlights of the 12th ISSPA Biennial Conference that was held in Pune, India. Convener Nirav Raveshia explained the reason behind the selection of the speakers and their topics. Paragon Paints research and development (R&D) manager K. K. Sengupta received the ISSPA...

  • ISSPA (Eastern Region) 5th Annual Meeting.  // Paintindia;Sep2009, Vol. 59 Issue 9, p140 

    The article discusses the highlights of the 5th annual meeting of the Indian Small Scale Paint Association (ISSPA) of the Eastern Region held at the Golden Park Hotel in Kolkata on August 23, 2009. Keynote speaker Doctor T. J. M. Sinha of Worlee Chemie GmbH talked about the concept to...

  • Ophthalmic Drug Facts. Loeffler, Michael // Ocular Surgery News;10/10/2014, Vol. 32 Issue 19, p56 

    No abstract available.

  • Glaucoma drugs aim for prolonged IOP control. Guttman, Cheryl // Ophthalmology Times;10/01/97, Vol. 22 Issue 19, p77 

    Speculates on the potency of future glaucoma drugs to prevent blindness and facilitate research aimed at understanding optic nerve changes. Role of glaucoma drugs in eliminating the confounding effect of periodic increases in intraocular pressure (IOP); Benefits of drugs that facilitate...

  • Brimonidine.  // Reactions Weekly;7/17/2010, Issue 1310, p14 

    The article describes the case of an elderly woman who developed pseudophaeochromocytoma while using brimonidine eye drops for glaucoma.

  • Tracking the Ophthalmic Pharmaceutical Market. Abelson, Mark B.; Chapin, Matthew J. // Review of Ophthalmology;Apr2003, Vol. 10 Issue 4, p41 

    Examines the market data concerning some ophthalmic drugs in the United States. Patterns of treatment; Diagnosis of the disease; Glaucoma medications.

  • European Study Assesses Xalacom. Stewart, William C. // Review of Ophthalmology;Jun2003, Vol. 10 Issue 6, p75 

    Examines the efficacy and safety of the ophthalmic drug Xalacom in Europe. Latanoprost/timolol maleate combination; Reasons for shifting to Xalacom; Intraocular pressure changes.

  • Glaucoma Drugs: Safer, More Powerful And More to Come. Netland, Peter // Review of Ophthalmology;Jun2000, Vol. 7 Issue 6, p41 

    Presents overview regarding the efficiency and usage of anti-glaucoma medications. Introduction of the types of non-selective beta-blockers; Impact of cholinergic drugs on intraocular pressure; Availability of carbonic anhydrase inhibitors; Adverse effects of each drugs; Mechanisms of action...

  • Clearing the Record on 4th-Generation Drugs. Blondeau, Joseph M. // Review of Ophthalmology;Jul2006 Part 1 of 2, Vol. 13 Issue 7, p22 

    A letter to the editor is presented in response to the article "When Fourth Generation Drugs are not Enough," in the March 2006 issue.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics